These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4691824)

  • 21. [Treatment of refractory ascites with clonidine and spironolactone].
    Lenaerts A; Van Cauter J; Moukaiber H; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 1997; 21(6-7):524-5. PubMed ID: 9295984
    [No Abstract]   [Full Text] [Related]  

  • 22. [Are diuretics in the treatment of portal hypertension rational?].
    Reichen J
    Praxis (Bern 1994); 1997 Apr; 86(14):583-9. PubMed ID: 9198853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
    Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
    Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ascites, pathogenesis and treatment (author's transl)].
    Borel GA
    Ther Umsch; 1973 Aug; 30(8):587-90. PubMed ID: 4751580
    [No Abstract]   [Full Text] [Related]  

  • 25. [Disorders of water and electrolyte equilibrium in liver diseases. Part 3: therapy (author's transl)].
    Kuntz E
    MMW Munch Med Wochenschr; 1982 May; 124(19):465-7. PubMed ID: 6810108
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Dölle W
    Internist (Berl); 1966 Jan; 7(1):48-54. PubMed ID: 4861685
    [No Abstract]   [Full Text] [Related]  

  • 27. [The place of diuretics in the treatment of cirrhotic ascites (apropos of 100 cases)].
    Levrat M; Truchot R
    Rev Int Hepatol; 1965; 15(7):1159-85. PubMed ID: 5860912
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anti-aldosterone therapy in cirrhosis of the liver with ascites].
    Loginov AS; Berezov VM
    Sov Med; 1967 Feb; 30(2):39-42. PubMed ID: 5597952
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hyperaldosteronism, spironolactone and liver cirrhosis].
    Sort P; Guevara M; Arroyo V
    Gastroenterol Hepatol; 1997 Mar; 20(3):151-9. PubMed ID: 9162537
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of ascites in hepatic cirrhosis].
    Arroyo JL; Bueno J; Rivero A; Lucas I; Ortiz de Landazuri E
    Rev Esp Enferm Apar Dig; 1966 Nov; 25(9):1021-46. PubMed ID: 5997895
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 32. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
    Haris A; Radó J
    Orv Hetil; 1996 Sep; 137(35):1907-14. PubMed ID: 8927344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of spironolactone and hydrochlorothiazide (separately and in combination) in cirrhotic edema.
    Munshi CP; Sawkar LA; Vaidya PM; Gulati OD
    J Assoc Physicians India; 1967 Dec; 15(12):583-9. PubMed ID: 4870785
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
    Radó JP; Molnár Z; Hartai A; Gercsák G
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):532-7. PubMed ID: 7174156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of symptomatic malignant ascites with diuretics: two case reports and a review of the literature.
    Sharma S; Walsh D
    J Pain Symptom Manage; 1995 Apr; 10(3):237-42. PubMed ID: 7629417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L; Candiori R
    Med Interna (Bucur); 1970 May; 22(5):573-92. PubMed ID: 5426383
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intrahepatic percutaneous portosystemic shunt and refractory ascites].
    Fernández-Esparrach G; Arroyo V
    Gastroenterol Hepatol; 1997 Nov; 20(9):459-60. PubMed ID: 9445741
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis].
    Furukawa T
    Saishin Igaku; 1965 Jul; 20(7):1743-58. PubMed ID: 5884753
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug therapy of ascites.
    Clearfield H
    Am Fam Physician; 1981 Jan; 23(1):204-5. PubMed ID: 7457316
    [No Abstract]   [Full Text] [Related]  

  • 40. Does the amount of edema in patients affect the magnitude of response to a dose of a diuretic acting on the renal tubules?
    Gold H; Messeloff CR; Mehta D; Kwit NT; Golfinos AJ; Zahm WN; Goessel E; Morris A
    J Clin Pharmacol J New Drugs; 1969; 9(6):374-83. PubMed ID: 5260200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.